We are live on ! Find out more
VNRX icon

VolitionRx Ltd

55 hedge funds and large institutions have $25M invested in VolitionRx Ltd in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 5

140% more capital invested

Capital invested by funds: $10.4M → $25M (+$14.6M)

77% more funds holding

Funds holding: 3155 (+24)

0.29% more ownership

Funds ownership: 0.41%0.7% (+0.29%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
55
Holders Change
+24
Holders Change %
+77.42%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
15
Reduced
5
Closed
2
Calls
$70K
Puts
Net Calls
+$70K
Net Calls Change
+$70K

VNRX Hedge Fund Activity: Q2 2020 in Review

55 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2020, worth a combined $25M — up 140% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new VNRX positions and 2 closed out — a net gain of 24 holders — while 15 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $6.09M. The largest seller was Millennium Management, exiting entirely with an estimated $454K sold.

  • 55 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2020, up from 31 in Q1 2020.
  • Funds reported $25M of VolitionRx Ltd stock for Q2 2020, up 140% quarter-over-quarter.
  • 26 funds opened new VolitionRx Ltd positions in Q2 2020 and 2 closed out, a net change of +24 holders.
  • The largest VolitionRx Ltd buyer in Q2 2020 was BlackRock, an estimated $6.09M added.
  • The largest VolitionRx Ltd seller in Q2 2020 was Millennium Management, an estimated $454K sold.

Based on aggregated 13F filings for Q2 2020.